Moving forward with the 21st Century Cures legislation in the lame duck session would be a “missed opportunity” to recraft the bill next Congress to deal with drug pricing, argues a coalition of groups including labor unions and consumer and patient advocates in a letter sent to House and Senate Democratic leadership and the ranking Democrats on two key committees Wednesday (Oct. 26). The push comes after House Minority Leader Nancy Pelosi (D-CA) said the bill would likely pass should...